{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:29:38Z","timestamp":1763987378816,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.biopha.2009.06.007","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T05:10:27Z","timestamp":1256274627000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2"],"prefix":"10.1016","volume":"64","author":[{"given":"Renhua","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-mei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu-hu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-qian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2009.06.007_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0303-7207(02)00096-5","article-title":"Sex hormones and liver cancer","volume":"193","author":"De Maria","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.biopha.2009.06.007_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopha.2009.06.007_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.2005.08.028","article-title":"Prevention of hormone-related cancers: breast cancer","volume":"23","author":"Dunn","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biopha.2009.06.007_bib4","first-page":"165","article-title":"Tamoxifen for the treatment of malignancies other than breast and endomerial carcinoma","volume":"24","author":"Gelmann","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.biopha.2009.06.007_bib5","first-page":"66","article-title":"Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma","volume":"26","author":"Elba","year":"1994","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.biopha.2009.06.007_bib6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0168-8278(05)80138-2","article-title":"Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma","volume":"20","author":"Martinez Cerezo","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.biopha.2009.06.007_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0168-8278(95)80038-7","article-title":"Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism","volume":"23","author":"Jiang","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.biopha.2009.06.007_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1478-3231.2004.00887.x","article-title":"Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity","volume":"24","author":"Brandt","year":"2004","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.biopha.2009.06.007_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.biopha.2008.09.010","article-title":"Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression","volume":"63","author":"Guo","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biopha.2009.06.007_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2009.06.007_bib11","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival:a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.biopha.2009.06.007_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.98.1.136","article-title":"A role of the kinase mTOR in cellular transformation induced by the oncoproteins PI3k and Akt","volume":"98","author":"Aoki","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopha.2009.06.007_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2009.06.007_bib14","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","article-title":"RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex","volume":"91","author":"Chiu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopha.2009.06.007_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2009.06.007_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/377441a0","article-title":"Control of p70s6 kinase activity of FRAP in vivo","volume":"377","author":"Brown","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2009.06.007_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1073\/pnas.95.4.1432","article-title":"RAFT1 phosphorylation of the translational regulators p70s6 kinase and 4E-BP1","volume":"95","author":"Burnett","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopha.2009.06.007_bib18","doi-asserted-by":"crossref","first-page":"34493","DOI":"10.1074\/jbc.274.48.34493","article-title":"Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro","volume":"274","author":"Isotani","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.06.007_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","article-title":"Targeting mTOR signaling for cancer therapy","volume":"3","author":"Huang","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biopha.2009.06.007_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.13.3.239","article-title":"IAP family proteins suppressors of apoptosis","volume":"13","author":"Deveraux","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.biopha.2009.06.007_bib21","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/sj.onc.1202569","article-title":"The inhibitors of apoptosis (IAPs) and their emerging role in cancer","volume":"17","author":"LaCasse","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2009.06.007_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.biopha.2009.06.007_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1471-4914(01)02243-2","article-title":"The molecular basis and potential role of survivin in cancer diagnosis and therapy","volume":"7","author":"Altieri","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.biopha.2009.06.007_bib24","first-page":"1327","article-title":"Survivin apoptosis; an interloper between cell death and cell proliferation in cancer","volume":"79","author":"Altieri","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.biopha.2009.06.007_bib25","first-page":"745","article-title":"Insulin\/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells","volume":"30","author":"Guo","year":"2008","journal-title":"Zhonghuazhongliuzazhi"},{"key":"10.1016\/j.biopha.2009.06.007_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0303-7207(01)00556-1","article-title":"Estradiol-induced IP(3) mediates the estrogen receptor activity expressed in human cells","volume":"182","author":"Mario","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.biopha.2009.06.007_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/039139880202500304","article-title":"Recent developments on human cell lines for the bioartificial liver","volume":"25","author":"Hoekstra","year":"2002","journal-title":"Int J Artif Org"},{"key":"10.1016\/j.biopha.2009.06.007_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3835(99)00284-0","article-title":"Involvement of Ca2+ influx in the mechanism of tamoxifen induced apoptosis in HepG2 human hepatoblastoma cells","volume":"147","author":"Kim","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/j.biopha.2009.06.007_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.cdd.4400717","article-title":"Role of NADPH oxidase in tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells","volume":"7","author":"Lee","year":"2000","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.biopha.2009.06.007_bib30","first-page":"5315","article-title":"IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas [CD95]. Bax, caspases, and anticancer drugs","volume":"58","author":"Tamm","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2009.06.007_bib31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"Li","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2009.06.007_bib32","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.273.18.11177","article-title":"Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting","volume":"273","author":"Ambrosini","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.06.007_bib33","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.1999.17.7.2100","article-title":"A novel anti-apoptosis gene: reexpression of survivin messenger RNA as a prognosis marker in non small cell lung cancers","volume":"17","author":"Monzo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biopha.2009.06.007_bib34","first-page":"5071","article-title":"Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer","volume":"58","author":"Kawasaki","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2009.06.007_bib35","first-page":"115","article-title":"Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities","volume":"11","author":"Nakagawara","year":"1998","journal-title":"Hum Cell"},{"key":"10.1016\/j.biopha.2009.06.007_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1368-7646(02)00049-3","article-title":"Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions","volume":"5","author":"Zaffaroni","year":"2002","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2009.06.007_bib37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2000.tb00906.x","article-title":"Survivin as a radioresistance factor in pancreatic cancer","volume":"91","author":"Asanuma","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.biopha.2009.06.007_bib38","first-page":"2805","article-title":"A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy","volume":"60","author":"Olie","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2009.06.007_bib39","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1242\/jcs.00612","article-title":"Survivin is required for stable checkpoint activation in taxol-treated HeLa cells","volume":"116","author":"Carvalho","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.biopha.2009.06.007_bib40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.1189704","article-title":"Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR [FOXO1]","volume":"18","author":"Daly","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.biopha.2009.06.007_bib41","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1074\/jbc.M310947200","article-title":"Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2\/M arrest","volume":"279","author":"Ling","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.06.007_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2006.07.057","article-title":"Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells","volume":"136","author":"Song","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.biopha.2009.06.007_bib43","first-page":"275","article-title":"Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides","volume":"14","author":"Ma","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.biopha.2009.06.007_bib44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3748\/wjg.v11.i5.756","article-title":"Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721","volume":"11","author":"Cheng","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biopha.2009.06.007_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(02)01009-7","article-title":"Identification of TOR signaling complexes: more TORC for the cell growth engine","volume":"111","author":"Abraham","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2009.06.007_bib46","doi-asserted-by":"crossref","first-page":"36079","DOI":"10.1074\/jbc.C100406200","article-title":"The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism","volume":"276","author":"Erbay","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.06.007_bib47","doi-asserted-by":"crossref","first-page":"16726","DOI":"10.1074\/jbc.M112285200","article-title":"Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin","volume":"277","author":"Shu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.06.007_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrm1018","article-title":"Tor signalling in bugs, brain and brawn","volume":"4","author":"Jacinto","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biopha.2009.06.007_bib49","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/hq0701.092104","article-title":"Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin","volume":"21","author":"Braun-Dullaeus","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.biopha.2009.06.007_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.biopha.2009.06.007_bib51","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/embo-reports\/kvf197","article-title":"The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase","volume":"3","author":"Choi","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1016\/j.biopha.2009.06.007_bib52","first-page":"339","article-title":"mTOR as a target for cancer therapy","volume":"279","author":"Houghton","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.biopha.2009.06.007_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR","volume":"15","author":"Gingras","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.biopha.2009.06.007_bib54","first-page":"295","article-title":"Inhibitors of mammalian target of rapamycin as novel antitumor agents:from bench to clinic","volume":"3","author":"Huang","year":"2002","journal-title":"Curr Opin Investig Drugs"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332209001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332209001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:45:46Z","timestamp":1760093146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332209001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0753332209001553"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2009.06.007","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2009.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}